Cited by 365Cardiomyopathy and Myosin StudiesCardiovascular Syncope and Autonomic DisordersCardiac electrophysiology and arrhythmias

Syncope and risk of sudden death in hypertrophic cardiomyopathy

Open access
Spirito, Paolo, Autore, Camillo, Rapezzi, Claudio, Bernabò, Paola, Badagliacca, Roberto, Maron, Martin S., Bongioanni, Sergio, Coccolo, Fabio +7 more·2009·Circulation

Abstract

BACKGROUND: The prognostic significance of syncope has not been investigated systematically in hypertrophic cardiomyopathy, and treatment strategies have been based largely on intuition and experience. METHODS AND RESULTS: We assessed the relationship between syncope and sudden death in 1511 consecutive patients with hypertrophic cardiomyopathy. Unexplained (n=153) or neurally mediated (n=52) syncope occurred in 205 patients (14%). Over a 5.6+/-5.2-year follow-up, 74 patients died suddenly. Relative risk of sudden death was 1.78 (95% confidence interval 0.88 to 3.51, P=0.08) in patients with unexplained syncope and 0.91 (95% confidence interval 0.00 to 3.83, P=1.0) in those with neurally mediated syncope compared with patients without syncope. In multivariable analysis, the temporal proximity of unexplained syncope to initial patient evaluation was independently associated with risk of sudden death (P=0.006). Patients with unexplained syncope within 6 months before the initial evaluation showed a 5-fold increase in risk compared with patients without syncope (adjusted hazard ratio 4.89, 95% confidence interval 2.19 to 10.94), a relationship that was maintained throughout all age groups (<18, 18 to 39, and > or =40 years). Older patients (> or =40 years of age) with remote episodes of syncope (>5 years before initial evaluation) did not show an increased risk of sudden death (adjusted hazard ratio 0.38, 95% confidence interval 0.05 to 2.74). CONCLUSIONS: In the present large cohort of patients with hypertrophic cardiomyopathy, unexplained syncope was a risk factor for sudden death. Patients with syncopal events that occurred in close temporal proximity to the initial evaluation showed a substantially higher risk of sudden death than patients without syncope. Older patients with remote syncopal events did not show an increased risk.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/circulationaha.108.798314

Cites

30 of 30 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • A history of syncope in patients with structural heart disease or inheritable arrhythmia syndromes is associated with a two- to four-fold increased risk of death, but this varies between specific conditions.

    “In general, a history of syncope in patients with structural heart disease or inheritable arrhythmia syndromes is associated with a two- to four-fold increased risk of death, 348,350-353 but varies between specific conditions. 354-356”

    From 2018 ESC Guidelines for the diagnosis and management of syncope (2018) · cites this paper as [354]

    The Abstract reports a relative risk of sudden death of 1.78 for unexplained syncope in patients with hypertrophic cardiomyopathy, but the confidence interval includes no increase; recent unexplained syncope carried a higher risk, while remote syncope in older patients did not. This supports variation in risk within hypertrophic cardiomyopathy, but the paper does not establish a general two- to four-fold increase across structural heart diseases or inheritable arrhythmia syndromes, or compare risk between those conditions. (LLM, conf=0.87)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 2

  1. McKenna W, Harris L, Deanfield J. Syncope in hypertrophic cardiomy- opathy. Br Heart J. 1982;47:177-179.
  2. Kapoor WN. Syncope. N Engl J Med. 2000;343:1856 -1862.

Cited by

Sorted by citations

Authors
Spirito, P., Autore, C., Rapezzi, C., Bernabò, P., Badagliacca, R., Maron, M. S., Bongioanni, S., Coccolo, F., Estes, N. A. M., Barillà, C. S., Biagini, E., Quarta, G., Conte, M. R., Bruzzi, P., & Maron, B. J.
Affiliations
  • Tufts Medical Center (US)
  • From the Ente Ospedaliero Ospedali Galliera (P.S., P. Bernabò), Genoa, Italy; Università La Sapienza (C.A., R.B., C.S.B., G.Q.), Roma, Italy; Universitá di Bologna (C.R., F.C., E.B.), Bologna, Italy; Tufts-New England Medical Center (M.S.M., N.A.M.E.), Boston, Mass; Ospedale di Rivoli (S.B., M.R.C.), Torino, Italy; Istituto Nazionale per la Ricerca sul Cancro (P. Bruzzi), Genoa, Italy; and Hypertrophic Cardiomyopathy Center of the Minneapolis Heart Institute Foundation (B.J.M.), Minneapolis, Minn.
Venue
Circulation
Published
2009-04-07
Volume
119
Issue
13
Pages
1703-1710
ISSN
  • 0009-7322 (ISSN-L)
  • 1524-4539
OpenAlex
W2103423712
Cited by
365
References
30
Citations by year
2026: 8 · 2025: 24 · 2024: 16 · 2023: 18 · 2022: 12 · 2021: 18 · 2020: 23 · 2019: 12 · 2018: 26 · 2017: 34 · 2016: 21 · 2015: 25 · 2014: 21 · 2013: 19 · 2012: 30
FWCI
18.84
Type
journal article
Language
en
Open access
Locations
  • Circulation (publishedVersion)
  • PubMed (publishedVersion)
  • Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion)
  • IRIS Research product catalog (Sapienza University of Rome) (submittedVersion)
  • Institutional Research Information System University of Ferrara (University of Ferrara) (submittedVersion, cc-by-nc-nd)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiomyopathy and Myosin Studies
  • Health Sciences › Medicine › Surgery › Cardiovascular Syncope and Autonomic Disorders
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
Keywords
hypertrophic cardiomyopathy, syncope, sudden death, unexplained syncope, neurally mediated syncope, risk factors, prognosis, age-related risk
MeSH terms
Adolescent, Adult, Aged, Cardiomyopathy, Hypertrophic, Female, Follow-Up Studies, Humans, Male, Middle Aged, Prognosis, Risk Factors, Syncope, Multivariate Analysis, Proportional Hazards Models, Death, Sudden, Cardiac, Defibrillators, Implantable, Age Distribution, Kaplan-Meier Estimate, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review